Skip to content

Raltegravir EP Impurity B

Raltegravir EP Impurity B

Product Description
CAT No.
ALN-R009003
CAS No.
1193687-85-2
Mol. F.
C19H24FN5O3
Mol. Wt.
389.4
Stock
Please Inquire
Chemical Name : 2-[2-[(E)-[(dimethylamino)methylidene]amino]propan-2-yl]-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide (as per EP); (E)-2-(2-{[(Dimethylamino)methylidene]amino}propan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide (as per USP)
Smiles : O=C(C(N=C(C(C)(/N=C/N(C)C)C)N1C)=C(O)C1=O)NCC2=CC=C(F)C=C2
Inchi : InChI=1S/C16H19FN4O3/c1-16(2,18)15-20-11(12(22)14(24)21(15)3)13(23)19-8-9-4-6-10(17)7-5-9/h4-7,22H,8,18H2,1-3H3,(H,19,23)
Synonym : Raltegravir Formididyl Analog

Development and validation of stability indicating RP-HPLC assay method of raltegravir in tablet dosage forms

By Shirisha, V.; Sairaju, B.; Illendula, Santhosh; Dutt, K. RajeswarnFrom World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(10), 668-692

Stability indicating reverse-phase high performance liquid chromatography method for the determination of raltegravir in bulk and pharmaceutical formulation

By Annapurna, Mukthinuthalapati Mathrusri; Teja, Gunnam Ravi; Hemchand, S.; Babu, R. Ravi Chandra – From International Journal of Green Pharmacy (2018), 12(1Suppl.), S177-S180

Development and validation of RP-HPLC method for determination of raltegravir and its impurities in bulk drug and dosage forms

By Balaji, M.; AppaRao, K. M. Ch.; Ramakrishna, K.; Srinivasarao, V. – From Pharma Science Monitor (2014), 5(3Suppl.1), 187-196, 10 pp.

Request For Quotation